首页> 外文期刊>Annals of nuclear medicine >Role of 18F-FDG PET-CT for evaluating the response to reducedintensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: Preliminary results in nine patients
【24h】

Role of 18F-FDG PET-CT for evaluating the response to reducedintensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: Preliminary results in nine patients

机译:18F-FDG PET-CT在评估重度预处理的慢性淋巴细胞白血病患者中对降低强度的同种异体移植的反应评估中的作用:9名患者的初步结果

获取原文
获取原文并翻译 | 示例
           

摘要

Objective The aim of our preliminary study was to evaluate the potential role of 18F-FDG PET-CT in monitoring response to reduced-intensity conditioning (RIC) transplant in a small series of chronic lymphocytic leukemia (CLL) patients and to compare the results with those obtained by standard criteria. Methods We retrospectively analyzed 9 consecutive refractory/relapsed CLL patients, who underwent RIC transplant fromMarch 2004 untilMay 2009. PET-CTwas planned at 6-8 months after transplant to assess response and at a mean of 6 months during follow-up. The mean long-term follow-up period was 38 months (range 12-74 months, median 29 months). Results The first PET-CT showed abnormal 18F-FDG uptake in five patients, while by standard criteria eight patients showed persistent disease. At the end of follow-up (mean 38 months), all four patients with previously negative scan were still PET negative and in complete remission by standard criteria. All five patients with previously positive scan were still PET positive: one patient died for disease progression and four are alive with disease. Conclusions Our preliminary data, although in a small series of CLL patients, suggest that the metabolic findings revealed at first PET-CT after transplant seem to predict the patient outcome and to assess the metabolic disease status earlier than clinical evaluation by standard criteria. PETCT performed during follow-up may be useful to early detect disease progression.
机译:目的我们的初步研究旨在评估18F-FDG PET-CT在监测一系列慢性淋巴细胞性白血病(CLL)患者对减低强度调节(RIC)移植的反应中的潜在作用,并将结果与通过标准条件获得的结果。方法我们回顾性分析了2004年3月至2009年5月接受RIC移植的9例连续难治性/复发性CLL患者。PET-CT计划在移植后6-8个月进行评估,平均随访6个月。平均长期随访期为38个月(范围12-74个月,中位数29个月)。结果首例PET-CT显示5例患者摄取18F-FDG异常,而按标准标准,有8例患者表现为持续性疾病。在随访结束时(平均38个月),所有4例先前扫描阴性的患者仍为PET阴性,并且按标准标准完全缓解。所有5例先前扫描阳性的患者仍为PET阳性:1例患者因疾病进展而死亡,而4例患者仍活着。结论我们的初步数据尽管是一小批CLL患者,但表明在移植后首次PET-CT上显示的代谢结果似乎可以预测患者的结局,并且比通过标准标准进行的临床评估更早评估代谢疾病的状态。随访期间进行的PETCT可能有助于早期发现疾病进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号